SHENZHEN HEPALINK PHARMACEUTICAL financial statements, including revenue, expenses, and profit
The total revenue of 9989 for the last quarter is 1.30 B HKD, and it's 2.96% lower compared to the previous quarter. The net income of Q4 24 is -144.23 M HKD.